FLOW trial and GLP-1 cost rant

Jun 4, 2024

Drs. Karl and Spencer discuss the FLOW trial showing kidney protection with semaglutide, rant about costly medicines, compounding considerations, and the need for heart and kidney health focus in diabetes management.

Ask episode

Chapters

Transcript

Episode notes

Clinical Trial on Type 2 Diabetes Patients with Kidney Disease

03:46 • 16min

Impact of Cardiometabolic Drugs on Weight Loss and Sugar Levels

19:32 • 12min

Pharmaceutical Costs and Marketing Practices

Discussion on reducing medication costs and the role of drug reps in promoting medications

Discussion on medical science liaisons, unnecessary marketing to patients, and frustration over Super Bowl commercial

Medication Costs and Healthcare System Frustrations